FAKTOR-OPTIONSSCHEIN - MERCK & CO. | Real-time Bid/Ask 06:00:53 2024-06-18 am EDT | ||
| 6.99 EUR / 7.12 EUR | -6.31% |
|
| Current month | -10.46% | ||
| 1 month | +9.61% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-18 | 7.01 | -6.91% |
| 24-06-17 | 7.53 | +3.29% |
| 24-06-14 | 7.29 | +1.25% |
| 24-06-13 | 7.2 | +3.90% |
| 24-06-12 | 6.93 | +5.64% |
Delayed Quote Börse Stuttgart
Last update June 18, 2024 at 02:51 am EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | Morgan Stanley |
| WKN | MG1371 |
| ISIN | DE000MG13713 |
| Date issued | 2024-03-26 |
| Strike | 153 $ |
| Maturity | Unlimited |
| Parity | 3.16 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.3 € |
|---|---|
| Lowest since issue | 6.39 € |
| Spread | 0.13 € |
| Spread % | 1.81% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
127.5
USD
Average target price
142.7
USD
Spread / Average Target
+11.91%
- Stock Market
- Certificates
- Certificat
